Veracyte, Inc. VCYT

Set alert

Price alert · VCYT

All alert types
49.00 USD -1.01 -2.02%

At close · Nov 2

49.00 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
48.99 × 2
Ask
49.13 × 2
48.90 Day range 50.61
29.46 52-week range 60.91
YTD
+16.39%
1 year
+35.81%
Open
50.43
Prev close
50.01
Mkt cap
3.94B
Vol
1.15M
Avg vol
1.31M
EPS
1.37
P/E
35.77
Div yield
0.00%
More statistics
Low
48.90
High
50.61
Forward P/E
25.22
Beta
1.96
Short ratio
6.64
Inst. own
115.10%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
44.42
200-d avg
42.82
1y target
59.73

5D chart

Chart tools
Interval

Signals (117)
NameTimeAgo
MACD: Sell SignalOct 30, 4:00 PM3 days ago
SMA: BearishOct 30, 3:55 PM3 days ago
SMA: BearishOct 30, 3:55 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
SMA: BearishOct 30, 2:20 PM3 days ago
SMA: BearishOct 30, 2:20 PM3 days ago
SMA: BullishOct 30, 2:00 PM3 days ago
SMA: BearishOct 30, 1:30 PM3 days ago
SMA: BearishOct 30, 1:30 PM3 days ago
SMA: BullishOct 30, 1:20 PM3 days ago
SMA: BullishOct 30, 1:15 PM3 days ago
MACD: Buy SignalOct 30, 12:25 PM3 days ago
MACD: Sell SignalOct 30, 11:45 AM3 days ago
SMA: BearishOct 30, 11:20 AM3 days ago
MACD: Buy SignalOct 30, 10:50 AM3 days ago
SMA: BullishOct 30, 10:40 AM3 days ago
RSI: OversoldOct 30, 9:50 AM3 days ago
SMA: BearishOct 30, 9:40 AM3 days ago
SMA: BullishOct 30, 9:35 AM3 days ago

Newest 20 of 117.

Revenue & Expenses

Revenue by
Testing → Revenue: $493.15MRevenue → Gross Profit: $360.05MGross Profit → Net Income: $66.35MGross Profit → Selling, General & Admin: $210.95MRevenue → Cost of Revenue: $157.10MGross Profit → Research & Development: $70.81MGross Profit → Other Operating Expenses: $4.13MGross Profit → Other Expenses: $5.95MGross Profit → Income Tax: $1.85MProduct → Revenue: $14.33MBiopharmaceutical And Other → Revenue: $9.66MGross Profit$360.05MCost of Revenue$157.10MNet Income$66.35MSelling, General & Admin$210.95MResearch & Development$70.81MOther Operating Expenses$4.13MOther Expenses$5.95MIncome Tax$1.85MRevenue$517.14MTesting$493.15MProduct$14.33MBiopharmaceutical And Other$9.66M

Latest period ending Dec 31, 2025 · select a line to chart its full history

VCYT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
517.14M445.76M361.05M296.54M219.51M
362.53M298.14M229.68M175.68M145.11M
57.78M16.14M-85.80M-41.08M-81.90M
66.35M24.14M-74.40M-36.56M-75.56M
0.820.31-1.02-0.51-1.11
VCYT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
364.23M240.63M217.33M155.00M173.95M
1.41B1.30B1.11B1.16B1.19B
96.44M124.07M70.80M81.22M91.31M
39.65M50.74M12.63M14.72M18.85M
1.31B1.18B1.04B1.08B1.10B
VCYT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
136.31M75.10M44.22M7.54M-31.62M
-9.21M-56.27M15.11M-29.39M-739.21M
-4.22M4.90M2.84M3.49M596.32M
-9.68M-11.29M-9.96M-8.55M-5.38M
122.88M23.73M62.17M-18.36M-174.51M